Vincerx Pharma, Inc. (VINC) Misses Q3 EPS by 25c

Vincerx Pharma, Inc. (NASDAQ: VINC) reported Q3 EPS of ($0.80), $0.25 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Vincerx Pharma, Inc. (VINC) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Macy's (M) Stock: Street Underestimates Earnings Pressure From Share Loss, Says Analyst
• DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print